Blog

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

Origin Sciences

Presenter:

Paul Weinberger, CEO

 

About:

Origin Sciences is bringing together two state-of-the-art technologies, a unique device for minimally invasive sampling of DNA-rich rectal mucosa plus advanced molecular analysis for tumour mutation detection, to create an end-to-end colorectal cancer screening service providing the optimum in performance and patient acceptability. By providing the best solution to physicians and patients, we aim to improve uptake, compliance & accuracy and thereby help reduce the suffering of colorectal cancer.